Skip to main content

Top Bar Menu

Go to LUNGevity.org › Sign Up For Emails

  • Non-Small Cell Lung Cancer
    • NSCLC
    • ALK
    • EGFR
    • KRAS
    • Rare Mutations
  • Small Cell Lung Cancer
  • Resources
    • Clinical Trials
    • Find a Cancer Center
    • Resource Library
    • Podcast

Go to LUNGevity.org › Sign Up For Emails

Patient Gateways

Top Bar Menu

Go to LUNGevity.org › Sign Up For Emails

  • Non-Small Cell Lung Cancer
    • NSCLC
    • ALK
    • EGFR
    • KRAS
    • Rare Mutations
  • Small Cell Lung Cancer
  • Resources
    • Clinical Trials
    • Find a Cancer Center
    • Resource Library
    • Podcast

Main navigation

Close Menu
  • Clinical Trials
  • Clinical Trials
  • Clinical Trials
  • Clinical Trials
  • Clinical Trials
  • Clinical Trials

You are about to leave the Patient Gateway

You’re one click away from learning about one of our most valued sponsors. Read about how they’re making a difference in patients’ lives.

ProceedCancel

Patient Gateway

RSS Feed

  • NSCLC Feed
  • ALK Feed
  • EGFR Feed
  • KRAS Feed
  • Rare Mutations Feed
  • SCLC Feed
In ES-SCLC, Oncologists Often Get Ahead of Formal Risk Categories to Prevent Febrile Neutropenia

Findings from Yamanashi Prefectural Central Hospital Yields New Data on Prostate Cancer (A Case of Synchronous Subcarinal Lymph Node Metastasis From Double Primary Cancers With...

Estela Rodriguez: Izalontamab Brengitecan Conjugate in Extensive-Stage Small Cell Lung Cancer

Atezolizumab Lowers Extensive-Stage Small Cell Lung Cancer Costs

Researchers at Hospital of the University of Pennsylvania Release New Data on Lung Cancer (Trends in Surgical Management of Early-stage Small Cell Lung Cancer)

New Lung Cancer Findings from Netherlands Cancer Institute Discussed (Real-world data on once or twice daily radiotherapy and the effect of age in patients with...

Treatment-stratified associations of pathological complete response with survival in resected limited-stage small cell lung cancer: A multicenter retrospective study with exploratory spatial immune profiling

Treatment-stratified associations of pathological complete response with survival in resected limited-stage small cell lung cancer: A multicenter retrospective study with exploratory spatial immune profiling

Defining the Objectives of an Analysis of Tarlatamab in Brain Metastases

Findings from University of Tokyo Hospital Broaden Understanding of Lung Cancer (Preoperative prognostic nutritional index predicts overall survival in surgically resected small cell lung cancer:...

SHARE

The Patient Gateways are a project of LUNGevity Foundation, an organization transforming how people are diagnosed and live with lung cancer. Learn more here.

Privacy policy | Contact us

 

This website is not intended to, and does not, provide medical advice, professional diagnosis, opinion, treatment, or services. Medical information provided on this site is for informational and educational purposes only. After reading content from this website, you are encouraged to review the information carefully with your physician.

 

Copyright © 2026 LUNGevity Foundation. All rights reserved.